Rocket Pharmaceuticals- Warrants (02/09/2026) Accounts Payable

Rocket Pharmaceuticals- Warrants (02/09/2026) (RCKTW) currently reports a accounts payable of $28M as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Rocket Pharmaceuticals- Warrants (02/09/2026)'s accounts payable history and peer comparisons.

Rocket Pharmaceuticals- Warrants (02/09/2026)'s accounts payable changed from $0 to $28M (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Rocket Pharmaceuticals- Warrants (02/09/2026) reported $28M in accounts payable as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $28M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Rocket Pharmaceuticals- Warrants (02/09/2026), and consider following RCKTW for alerts when major investors trade the stock.

Rocket Pharmaceuticals- Warrants (02/09/2026) is classified in the Healthcare sector. On accounts payable, it currently shows $28M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RCKTW with unrelated industries.